PTGS2 and cancer: AE-COS (500 μg mL−1) has appreciably blocked the expression of cyclooxygenase-2 (COX-2) and Bcl-2 while upregulating the expression of apoptotic proteins caspase-3 and 9 in A549 cancer cells.